106 related articles for article (PubMed ID: 10372995)
1. Intravitreally injected platelet activating factor induces retinitis in experimental animals.
Rosenbaum JT; Angell E; Wilson D; Broquet C; Boney RS; Braquet P
Curr Eye Res; 1999 May; 18(5):342-8. PubMed ID: 10372995
[TBL] [Abstract][Full Text] [Related]
2. Differences in the acyl composition of the platelet-activating factor (PAF) precursor and other choline phosphoglycerides of the rabbit retinal rod outer segments and neural retina.
Bazan HE; Hurst JS; Bazan NG
Curr Eye Res; 1994 Jan; 13(1):45-50. PubMed ID: 8156825
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo.
Sato A; Oe K; Yamanaka H; Yokoyama I; Ebina K
Eur J Pharmacol; 2014 Dec; 745():46-51. PubMed ID: 25455842
[TBL] [Abstract][Full Text] [Related]
4. Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF.
Okamoto M; Yoshida K; Nishikawa M; Kohsaka M; Aoki H
Thromb Res; 1986 Jun; 42(5):661-71. PubMed ID: 3754990
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor and its metabolite promote sleep in rabbits.
Kushikata T; Fang J; Krueger JM
Neurosci Lett; 2006 Feb; 394(3):233-8. PubMed ID: 16263215
[TBL] [Abstract][Full Text] [Related]
6. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
7. Production of platelet-activating factor in photocoagulated retinas.
Dharma S; Bazan HE; Peyman GA; Atef MS
Curr Eye Res; 1991 Nov; 10(11):1031-5. PubMed ID: 1782801
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
9. Intracamerally injected platelet activating factor (PAF) induces marked intraocular inflammatory reactions.
Sheng Y; Birkle DL
Curr Eye Res; 1992 Nov; 11(11):1067-78. PubMed ID: 1483337
[TBL] [Abstract][Full Text] [Related]
10. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory.
Teather LA; Packard MG; Bazan NG
Neurobiol Learn Mem; 1998 Nov; 70(3):349-63. PubMed ID: 9774526
[TBL] [Abstract][Full Text] [Related]
11. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats.
Sato A; Yokoyama I; Ebina K
Peptides; 2015 Nov; 73():60-6. PubMed ID: 26348270
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
15. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
16. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor.
Brewer C; Bonin F; Bullock P; Nault MC; Morin J; Imbeault S; Shen TY; Franks DJ; Bennett SA
J Neurochem; 2002 Sep; 82(6):1502-11. PubMed ID: 12354298
[TBL] [Abstract][Full Text] [Related]
18. Mediators of the ocular inflammatory response to interleukin-1 beta plus tumor necrosis factor-alpha.
Fleisher L; Ferrell J; McGahan C
Graefes Arch Clin Exp Ophthalmol; 1995 Feb; 233(2):94-100. PubMed ID: 7729711
[TBL] [Abstract][Full Text] [Related]
19. Role of neutrophils in breakdown of the blood-retinal barrier following intravitreal injection of platelet-activating factor.
Smith D; Lee EK; Saloupis P; Davis JK; Hatchell DL
Exp Eye Res; 1994 Oct; 59(4):425-32. PubMed ID: 7859817
[TBL] [Abstract][Full Text] [Related]
20. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
